4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-18-006818
Chief Medical Officer acquired 4,774 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Clark David J Chief Medical Officer | 2017-12-29 | Grant or award | +4,774 | $4.00 | $19,072 | 4,774 | D |
| Derivatives | |||||||
| Clark David J Chief Medical Officer | 2018-03-06 | Grant or award · Employee Stock Option (Right to Buy) | +108,633 | 108,633 | D | ||
Loading xslF345X03/doc4.xml…